---
title: "Neuroinflammation"
canonical: "https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/neuroinflammation/"
lastmod: "2026-07-02T21:31:36+00:00"
generator: "llm-mirrors/1.0.19"
---

The first ever recorded description of a neuroinflammatory disorder goes as far back as the 1200s. Defined as the result of chronic inflammation in the Central Nervous System (CNS), neuroinflammation can be caused by both chronic events in the form of neurodegenerative disorders (Alzheimer’s, Prakinson’s and Huntington’s diseases) and acute events like viral infections and traumatic brain injuries.
The costs from neurodegenerative diseases are north of $655 billion per year in medical expenses and economic losses.
While novel therapies are emerging every day, most early clinical trials have fallen short of achieving satisfactory therapeutic effect. This only drives us forward at PharmaLegacy to support you in your preclinical trials, providing you with all the rigorous data you need for your neuroinflammation pipelines.